{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:07:20Z","timestamp":1790701640533,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012421","name":"Agricultural Science and Technology Innovation Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012421","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003052","name":"Korea Ministry of Trade Industry and Energy","doi-asserted-by":"publisher","award":["RS-2024-00468354"],"award-info":[{"award-number":["RS-2024-00468354"]}],"id":[{"id":"10.13039\/501100003052","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jpet.2026.104998","type":"journal-article","created":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T07:09:05Z","timestamp":1785481745000},"page":"104998","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["CE9A215 (inotodiol) ameliorates oxazolone-induced atopic dermatitis by targeting mast cells and proinflammatory cytokines"],"prefix":"10.1016","volume":"393","author":[{"given":"Thi Minh Nguyet","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thi Thuong","family":"Do","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0598-5649","authenticated-orcid":false,"given":"Soyoung","family":"Ban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6160-9715","authenticated-orcid":false,"given":"Su Been","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Van Dinh","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Tae","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyunjung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.jpet.2026.104998_bib1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000370220","article-title":"Atopic dermatitis: global epidemiology and risk factors","volume":"66","author":"Nutten","year":"2015","journal-title":"Ann Nutr Metab"},{"issue":"6","key":"10.1016\/j.jpet.2026.104998_bib2","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.jaci.2009.10.009","article-title":"ISAAC Phase Three Study Group. Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three","volume":"124","author":"Odhiambo","year":"2009","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.jpet.2026.104998_bib3","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/pde.12867","article-title":"Study of the atopic march: development of atopic comorbidities","volume":"33","author":"Schneider","year":"2016","journal-title":"Pediatr Dermatol"},{"issue":"9","key":"10.1016\/j.jpet.2026.104998_bib4","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1111\/exd.14003","article-title":"Effects of \u03b2-carotene on oxazolone-induced atopic dermatitis in hairless mice","volume":"28","author":"Kake","year":"2019","journal-title":"Exp Dermatol"},{"issue":"12","key":"10.1016\/j.jpet.2026.104998_bib5","doi-asserted-by":"crossref","first-page":"e70024","DOI":"10.1111\/exd.70024","article-title":"Characterisation and profiling of standard atopic dermatitis therapies in a chronic dermatitis murine model induced by oxazolone","volume":"33","author":"Calama","year":"2024","journal-title":"Exp Dermatol"},{"issue":"1","key":"10.1016\/j.jpet.2026.104998_bib6","doi-asserted-by":"crossref","first-page":"44385","DOI":"10.1038\/srep44385","article-title":"Sensitivity to oxazolone induced dermatitis is transferable with gut microbiota in mice","volume":"7","author":"Zachariassen","year":"2017","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.jpet.2026.104998_bib7","doi-asserted-by":"crossref","first-page":"120","DOI":"10.5415\/apallergy.2016.6.2.120","article-title":"A review on the role of moisturizers for atopic dermatitis","volume":"6","author":"Giam","year":"2016","journal-title":"Asia Pac Allergy"},{"issue":"8","key":"10.1016\/j.jpet.2026.104998_bib8","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1080\/09546634.2019.1655137","article-title":"Atopic dermatitis epidemiology and unmet need in the United Kingdom","volume":"31","author":"Cork","year":"2020","journal-title":"J Dermatolog Treat"},{"issue":"8","key":"10.1016\/j.jpet.2026.104998_bib9","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.3390\/ijms17081234","article-title":"Molecular mechanisms of cutaneous inflammatory disorder: atopic dermatitis","volume":"17","author":"Kim","year":"2016","journal-title":"Int J Mol Sci"},{"issue":"10","key":"10.1016\/j.jpet.2026.104998_bib10","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1111\/all.14791","article-title":"Interleukin-31: the \u201citchy\u201d cytokine in inflammation and therapy","volume":"76","author":"Datsi","year":"2021","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.jpet.2026.104998_bib11","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/all.13239","article-title":"Emerging role of interleukin-31 and interleukin-31 receptor in pruritus in atopic dermatitis","volume":"73","author":"Furue","year":"2017","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.jpet.2026.104998_bib12","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12950-023-00360-z","article-title":"Advances in the study of macrophage polarization in inflammatory immune skin diseases","volume":"20","author":"Xia","year":"2023","journal-title":"J Inflamm"},{"issue":"5","key":"10.1016\/j.jpet.2026.104998_bib13","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/jdv.14891","article-title":"Consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I","volume":"32","author":"Wollenberg","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"7421","key":"10.1016\/j.jpet.2026.104998_bib14","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1136\/bmj.327.7421.942","article-title":"Topical corticosteroids in atopic dermatitis","volume":"327","author":"Atherton","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.jpet.2026.104998_bib15","doi-asserted-by":"crossref","unstructured":"Drucker AM, Eyerich K, de Bruin-Weller MS, et al. Use of systemic corticosteroids for atopic dermatitis: International Eczema Council consensus statement. 2018;178(3):768\u2013775. 775. https:\/\/doi.org\/10.1111\/bjd.15928.","DOI":"10.1111\/bjd.15928"},{"key":"10.1016\/j.jpet.2026.104998_bib16","doi-asserted-by":"crossref","first-page":"117895","DOI":"10.1016\/j.biopha.2025.117895","article-title":"Liver-X receptor \u03b2-selective agonist CE9A215 regulates Alzheimer\u2019s disease-associated pathology in a 3xTg-AD mouse model","volume":"184","author":"Ban","year":"2025","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jpet.2026.104998_bib17","doi-asserted-by":"crossref","first-page":"176836","DOI":"10.1016\/j.ejphar.2024.176836","article-title":"CE9A215 (inotodiol), a lanostane-type oxysterol, mitigates LPS-induced sepsis through multifaceted mechanisms","volume":"980","author":"Nguyet Nguyen","year":"2024","journal-title":"Eur J Pharmacol"},{"issue":"20","key":"10.1016\/j.jpet.2026.104998_bib18","doi-asserted-by":"crossref","first-page":"5085","DOI":"10.1158\/1078-0432.CCR-18-0873","article-title":"Mast cell activation and KSHV infection in Kaposi sarcoma","volume":"24","author":"Ayers","year":"2018","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.jpet.2026.104998_bib19","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jaci.2004.10.003","article-title":"The Chinese herbal medicine formula FAHF-2 completely blocks anaphylactic reactions in a murine model of peanut allergy","volume":"115","author":"Srivastava","year":"2005","journal-title":"J Allergy Clin Immunol"},{"issue":"15","key":"10.1016\/j.jpet.2026.104998_bib20","doi-asserted-by":"crossref","first-page":"4704","DOI":"10.3390\/molecules27154704","article-title":"Evaluation of toxicity and efficacy of inotodiol as an anti-inflammatory agent using animal model","volume":"27","author":"Nguyen","year":"2022","journal-title":"Molecules"},{"issue":"5A","key":"10.1016\/j.jpet.2026.104998_bib21","first-page":"2691","article-title":"Inotodiol, a lanostane triterpenoid, from Inonotus obliquus inhibits cell proliferation through caspase-3-dependent apoptosis","volume":"28","author":"Nomura","year":"2008","journal-title":"Anticancer Res"},{"issue":"1\u20134","key":"10.1016\/j.jpet.2026.104998_bib22","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.foodchem.2013.01.030","article-title":"Anti-inflammatory and anticancer activities of extracts and compounds from the mushroom Inonotus obliquus","volume":"139","author":"Ma","year":"2013","journal-title":"Food Chem"},{"key":"10.1016\/j.jpet.2026.104998_bib23","doi-asserted-by":"crossref","first-page":"113321","DOI":"10.1016\/j.jep.2020.113321","article-title":"Deciphering the antitumoral potential of the bioactive metabolites from medicinal mushroom Inonotus obliquus","volume":"265","author":"Zhao","year":"2021","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.jpet.2026.104998_bib24","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.biopha.2017.12.084","article-title":"Inotodiol suppresses proliferation of breast cancer in rat model of type 2 diabetes mellitus via downregulation of \u03b2-catenin signaling","volume":"99","author":"Zhang","year":"2018","journal-title":"Biomed Pharmacother"},{"issue":"12","key":"10.1016\/j.jpet.2026.104998_bib25","doi-asserted-by":"crossref","first-page":"e70029","DOI":"10.1002\/mco2.70029","article-title":"Atopic dermatitis: pathogenesis and therapeutic intervention","volume":"5","author":"Yue","year":"2024","journal-title":"MedComm"},{"issue":"8","key":"10.1016\/j.jpet.2026.104998_bib26","doi-asserted-by":"crossref","first-page":"e2250359","DOI":"10.1002\/eji.202250359","article-title":"Mast cells in type 2 skin inflammation: maintenance and function","volume":"53","author":"Keith","year":"2023","journal-title":"Eur J Immunol"},{"issue":"10","key":"10.1016\/j.jpet.2026.104998_bib27","doi-asserted-by":"crossref","DOI":"10.2340\/actadv.v101.350","article-title":"Role of mast cells in the pathogenesis of pruritus in mastocytosis","volume":"101","author":"Kwiatkowska","year":"2021","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jpet.2026.104998_bib28","doi-asserted-by":"crossref","first-page":"942375","DOI":"10.1155\/2013\/942375","article-title":"Role of macrophages in the pathogenesis of atopic dermatitis","volume":"2013","author":"Kasraie","year":"2013","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.jpet.2026.104998_bib29","doi-asserted-by":"crossref","first-page":"106244","DOI":"10.1016\/j.intimp.2020.106244","article-title":"Anti-allergic effect of inotodiol, a lanostane triterpenoid from Chaga mushroom, via selective inhibition of mast cell function","volume":"81","author":"Nguyen","year":"2020","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.jpet.2026.104998_bib30","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.intimp.2017.11.025","article-title":"The mast cell stabilizing activity of Chaga mushroom critical for its therapeutic effect on food allergy is derived from inotodiol","volume":"54","author":"Nguyet","year":"2018","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"10.1016\/j.jpet.2026.104998_bib31","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1600-0846.2004.00062.x","article-title":"Establishment of an atopic dermatitis-like skin model in a hairless mouse by repeated elicitation of contact hypersensitivity that enables to conduct functional analyses of the stratum corneum with various non-invasive biophysical instruments","volume":"10","author":"Matsumoto","year":"2004","journal-title":"Skin Res Technol"},{"issue":"1","key":"10.1016\/j.jpet.2026.104998_bib32","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/sj.jid.5701011","article-title":"Characterization of a hapten-induced, murine model with multiple features of atopic dermatitis: structural, immunologic, and biochemical changes following single versus multiple oxazolone challenges","volume":"128","author":"Man","year":"2008","journal-title":"J Invest Dermatol"},{"issue":"6","key":"10.1016\/j.jpet.2026.104998_bib39","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.jaci.2008.07.031","article-title":"The functional activity of basophil granulocytes is modulated by acute mental stress and sympathetic activation in vivo and in vitro","volume":"122","author":"Raap","year":"2008","journal-title":"J Allergy Clin Immunol"},{"issue":"7","key":"10.1016\/j.jpet.2026.104998_bib40","doi-asserted-by":"crossref","first-page":"3717","DOI":"10.4049\/jimmunol.1401307","article-title":"Basophils promote innate lymphoid cell responses in inflamed skin","volume":"193","author":"Kim","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.jpet.2026.104998_bib33","doi-asserted-by":"crossref","first-page":"923495","DOI":"10.3389\/fimmu.2022.923495","article-title":"Roles of mast cells in cutaneous diseases","volume":"13","author":"Numata","year":"2022","journal-title":"Front Immunol"},{"issue":"16","key":"10.1016\/j.jpet.2026.104998_bib34","doi-asserted-by":"crossref","first-page":"12803","DOI":"10.3390\/ijms241612803","article-title":"Protective effects of lanostane triterpenoids from Chaga mushroom in human keratinocytes, HaCaT cells, against inflammatory and oxidative stresses","volume":"24","author":"Park","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jpet.2026.104998_bib35","doi-asserted-by":"crossref","first-page":"113311","DOI":"10.1016\/j.biopha.2022.113311","article-title":"Antiaging effect of inotodiol on oxidative stress in human dermal fibroblasts","volume":"153","author":"Lee","year":"2022","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"10.1016\/j.jpet.2026.104998_bib36","doi-asserted-by":"crossref","first-page":"12874","DOI":"10.1038\/s41598-024-62828-z","article-title":"The beneficial effects of ethanolic extract of Sargassum serratifolium in DNCB-induced mouse model of atopic dermatitis","volume":"14","author":"Kim","year":"2024","journal-title":"Sci Rep"},{"issue":"2","key":"10.1016\/j.jpet.2026.104998_bib37","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3390\/nu12020411","article-title":"Inhibitory effect of centella asiatica extract on DNCB-induced atopic dermatitis in HaCaT cells and BALB\/c mice","volume":"12","author":"Lee","year":"2020","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.jpet.2026.104998_bib38","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/s41598-023-50257-3","article-title":"Evodiae Fructus extract suppresses inflammatory response in HaCaT cells and improves house dust mite-induced atopic dermatitis in NC\/Nga mice","volume":"14","author":"Jin","year":"2024","journal-title":"Sci Rep"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356526011985?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356526011985?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:44:36Z","timestamp":1790700276000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356526011985"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":40,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0022356526011985"],"URL":"https:\/\/doi.org\/10.1016\/j.jpet.2026.104998","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CE9A215 (inotodiol) ameliorates oxazolone-induced atopic dermatitis by targeting mast cells and proinflammatory cytokines","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpet.2026.104998","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104998"}}